doxylamine succinate; pyridoxine hydrochloride · Duchesnay · NDA 209661
Bonjesta
Earliest generic entry, as listed
18 Feb 2033
Blocked by patent: US 9089489, US 9375404, US 9526703, US 9937132.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9089489 | drug product, use U-1382 · sets the listed date | 18 Feb 2033 |
| US 9375404 | drug product, use U-1382 · sets the listed date | 18 Feb 2033 |
| US 9526703 | drug product, use U-1382 · sets the listed date | 18 Feb 2033 |
| US 9937132 | drug product, use U-1382 · sets the listed date | 18 Feb 2033 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209661 · 001 · RLD | tablet, extended release, oral | 20MG;20MG | 18 Feb 2033 |